Quick Answer
Centessa Pharmaceuticals plc reported Stockholders Equity of $526.86 million for fiscal year 2025.
Centessa Pharmaceuticals plc Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $526.86M | +31.2% |
| 2024 | $401.55M | +70.0% |
| 2023 | $236.24M | -29.7% |
| 2022 | $336.17M | -31.6% |
| 2021 | $491.55M | +10668.8% |
| 2021 | -$4.65M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $301.57M | -39.6% | -12.6% |
| June 30, 2025 | $344.92M | +20.2% | -10.7% |
| March 31, 2025 | $386.25M | +79.5% | -3.8% |
| December 31, 2024 | $401.55M | +70.0% | -19.6% |
| September 30, 2024 | $499.14M | +92.4% | +73.9% |
| June 30, 2024 | $286.96M | +3.7% | +33.4% |
| March 31, 2024 | $215.16M | -26.6% | -8.9% |
| December 31, 2023 | $236.24M | -29.7% | -8.9% |
- Centessa Pharmaceuticals plc showed an increase of +31.2% in Stockholders Equity compared to the prior fiscal year.
- Over the 2021–2025 period, Centessa Pharmaceuticals plc’s stockholders equity has grown by 11428.0% (from -$4.65 million to $526.86 million).
- The most recent figure is from Centessa Pharmaceuticals plc’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: